Ruling Out 131I Ablation in Low-Risk Differentiated Thyroid Carcinoma Basing on Thyroglobulin Measurement Response

被引：0
|
作者：
Rosario, Pedro Weslley [1 ,2 ]
机构：
[1] Santa Casa Belo Horizonte, Postgrad Program, BR-30150221 Belo Horizonte, MG, Brazil
[2] Santa Casa Belo Horizonte, Serv Endocrinol, BR-30150221 Belo Horizonte, MG, Brazil
来源：
THYROID | 2011年 / 21卷 / 07期
关键词：
RECURRENCE; CANCER;
D O I：
10.1089/thy.2010.0435.rs
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：811 / 812
页数：2
相关论文
共 50 条
  • [1] Ruling Out 131I Ablation in Low-Risk Differentiated Thyroid Carcinoma Basing on Thyroglobulin Measurement
    Giovanella, Luca
    Verburg, Frederik A.
    [J]. THYROID, 2011, 21 (07) : 809 - 810
  • [2] LETTER TO THE EDITOR: THYROGLOBULIN-GUIDED 131I ABLATION IN LOW-RISK DIFFERENTIATED THYROID CARCINOMA: IS THE YARDSTICK ACCURATE ENOUGH?
    Giovanella, Luca
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (09): : 1379 - 1380
  • [3] LETTER TO THE EDITOR: THYROGLOBULIN-GUIDED 131I ABLATION IN LOW-RISK DIFFERENTIATED THYROID CARCINOMA: IS THE YARDSTICK ACCURATE ENOUGH? Reply
    Vaisman, Alon
    Orlov, Steven
    Yip, Jonathan
    Freeman, Jeremy L.
    Walfish, Paul G.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (09): : 1380 - 1381
  • [4] Role of 131I in low-risk differentiated thyroid cancer
    Vallejo, J. A.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (01): : 33 - 37
  • [5] Is 131I ablation necessary for patients with low-risk papillary thyroid carcinoma and slightly elevated stimulated thyroglobulin after thyroidectomy?
    Rosario, Pedro Weslley
    Mourao, Gabriela Franco
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (01): : 5 - 8
  • [6] Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma
    Giovanella, Luca
    Ceriani, Luca
    Suriano, Sergio
    Ghelfo, Antonella
    Maffioli, Marco
    [J]. CLINICAL ENDOCRINOLOGY, 2008, 69 (04) : 659 - 663
  • [7] Empiric 131I Treatment of High Thyroglobulin Levels in Differentiated Thyroid Carcinoma After Remmant Ablation
    Kalender, E.
    Elboga, U.
    Celen, Y.
    Demir, H.
    Sahin, E.
    Yilmaz, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S503 - S503
  • [8] EMPIRIC 131I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION
    Kalender, Ebuzer
    Elboga, Umut
    Celen, Y. Zeke
    Demir, H. Deniz
    Sahin, Ertan
    Karacavus, Seyhan
    [J]. ACTA MEDICA MEDITERRANEA, 2014, 30 (02): : 503 - 507
  • [9] Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma
    Kim, TY
    Kim, WB
    Kim, ES
    Ryu, JS
    Yeo, JS
    Kim, SC
    Hong, SJ
    Shong, YK
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03): : 1440 - 1445
  • [10] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
12345